New research into the dying brain suggests the line between life and death may be less distinct than previously thought.
Read moreNatural Mushroom vs. Synthesized Psilocybin
Psychedelics, Psychosis and Manic Symptoms
In the twin data researchers reviewed, mania was also strongly correlated with a genetic predisposition to schizophrenia and to bipolar I disorder.
In other words, those who experienced manic symptoms after psychedelic use may have been more genetically prone to mental illnesses.
Read moreCognitive Impairment, Dementia, Alzheimer’s and Psychedelics
Here’s an interview with researcher Albert Garcia-Romeu, where he discusses the potential of psilocybin to address issues associated with cognitive decline, and noteworthy preliminary observations from his research.
Read moreChronic Pain and Psychedelics
Chronic pain could be treated by psychedelics in the future.
Keep reading for more information on clinical trial research on using psychedelics for chronic pain.
Read morePsychedelics, Alzheimer’s Disease and Related Dementias
Psychedelics may have a role in treating Alzheimer’s disease and related dementias.
Read the latest research insights and treatment approaches.
Read morePhantom Pain and Psilocybin
Phantom pain and psilocybin are a growing area of research.
Psilocybin may be a treatment for this debilitating condition in the future.
Read moreDeathbed Visions
Deathbed visions can teach us about living.
Researchers are documenting a phenomenon that seems to help the dying, as well as those they leave behind.
Read moreVideo: The Global Psychedelic Survey, Primary Outcomes
The Importance of Therapy!
A study published recently in PLOS One suggests that therapy may, in fact, play an important role in psilocybin-assisted therapy for major depressive disorder.
In a study of 24 participants with MDD, those who reported stronger alliance, or “sense of collaboration between patient and client,” with their therapist were more likely to show improvements in their depression scores after two psilocybin dosing sessions.
Stronger ratings of therapeutic alliance during the study’s final preparation session were correlated with improved depression scores for 12 months after the study.
Read moreOn Death and Dying
This article asks- is a “good death” a good idea?
Read more